Abstract 294. Exploiting mutant PPM1D-induced metabolic defects with nanoparticle-encapsulated NAMPT inhibitors.
Please share information about how the pandemic has impacted your research over the last two years.
The pandemic has been particularly hard for my research progress over the past two years because I work within a primarily wet-lab setting. This has led to 1) an inability to come in and perform experiments because of our main quarantine period, 2) shortened time in the lab due to social distancing concerns, and 3) required 10 days to two weeks of quarantining due to COVID exposure. All of this together has significantly inhibited my ability to push my wet-lab experiments forward. However, the increased time at home has benefitted other skills such as the utilization of bioinformatical approaches to work on my research aims and also lend more time to reading and planning out experiments for when I can be in lab. Together, the pandemic may have significantly impacted my ability to be on the bench, but this resulted in trying to progress my biological understanding of the work I’m doing in new lenses I may have not had the opportunity to explore before.